Catatonia affects roughly 9% of acute psychiatric inpatients, making it far more common than most people realize. A large meta-analysis pooling over 110,000 patients across 80 studies found a mean prevalence of 9%, with a narrower estimate of about 7.8% when researchers controlled for statistical inconsistencies between studies. Despite these numbers, the condition is widely underdiagnosed, and many cases are missed entirely during hospital stays.
Overall Prevalence in Psychiatric Settings
The most reliable modern estimate comes from a meta-analysis published in Schizophrenia Bulletin, which found that about 1 in 11 acute psychiatric inpatients meets criteria for catatonia. That 9% figure holds fairly steady across different hospitals and countries. When researchers excluded patients already receiving electroconvulsive therapy or those with certain lab markers that might inflate numbers, the rate dipped slightly to 8.1%.
These numbers are strikingly high for a condition many clinicians rarely diagnose. To put it in perspective, catatonia is more common among psychiatric inpatients than many well-known conditions are in the general population.
Which Conditions Carry the Highest Risk
Catatonia was historically linked almost exclusively to schizophrenia, but the data tells a different story. Mood disorders, particularly bipolar disorder and severe depression, account for a large and growing share of cases. Prevalence rates in mood disorder populations range from 13% to 31%, while among people with chronic schizophrenia the rate reaches around 30%. For acute psychotic episodes more broadly, between 6% and 38% of patients show catatonic features depending on the study and the screening tools used.
The proportion of catatonia cases tied to mood disorders has roughly doubled over recent decades. One long-running study found that mood disorders accounted for about 10% of catatonia cases in the early 1980s but had risen to nearly 21% by the mid-2000s. Meanwhile, schizophrenia’s share dropped from 82.5% to 53.4% over the same period. This shift likely reflects both changing diagnostic habits and a genuine recognition that catatonia crosses diagnostic boundaries.
Autism Spectrum Disorder
A meta-analysis in European Psychiatry found that about 10.4% of people with autism spectrum disorder develop catatonia, with onset typically peaking between ages 15 and 19. Cross-sectional studies put the rate at 12.1%, while longitudinal studies tracking people over time found that 8% developed catatonic symptoms during follow-up. The average age of affected individuals was around 21, suggesting this is primarily a concern during late adolescence and early adulthood.
Dementia in Older Adults
Catatonia rates in elderly patients with dementia are surprisingly high. Two prospective studies in psychogeriatric wards found that 35% to 43% of dementia patients met criteria for catatonia. On general psychiatric wards, the rate was much lower at about 4.7%, suggesting that the combination of advanced cognitive decline, medical complications, and certain medications creates a particularly high-risk environment. In the vast majority of these cases (over 93%), dementia itself wasn’t the direct cause. Instead, catatonia arose from acute medical problems, new psychiatric symptoms, or medication effects, particularly from antipsychotic drugs.
How Often It Gets Missed
Catatonia is dramatically underdiagnosed. One large retrospective study screened nearly 15,000 hospital admissions and found that only 54 patients had received a formal catatonia diagnosis. When researchers independently reviewed discharge records using standardized criteria, they identified 183 additional patients who clearly met the diagnostic threshold but were never diagnosed. That means roughly three out of four cases went unrecognized.
A smaller chart review found similar results: of 18 patients meeting catatonia criteria, only 2 had been formally diagnosed. The pattern is consistent across studies. Clinicians tend to recognize the classic “frozen” presentation, where a patient is immobile and unresponsive, but frequently miss cases involving excessive or unusual movements, repetitive behaviors, or echo-like imitation of others’ speech and actions.
Part of the problem is that catatonia requires at least three out of twelve recognized features to be present simultaneously. These features range from stupor and mutism to agitation, stereotyped movements, grimacing, and a waxy resistance to being repositioned. When symptoms are subtle or mixed with other psychiatric presentations, they’re easy to attribute to something else entirely.
Has Catatonia Become Rarer Over Time?
There’s a widespread belief that catatonia has become less common since the mid-20th century. Finnish registry data does show a drop in catatonic schizophrenia diagnoses between the 1950s and 1970s, especially among people aged 25 to 40. But researchers caution that this apparent decline likely reflects changes in how clinicians classify and record diagnoses rather than a true decrease in the condition itself. The introduction of antipsychotic medications may have also masked or partially treated catatonic symptoms, making them less obvious without actually eliminating the underlying syndrome.
What has genuinely changed is the severity of the most dangerous form. Malignant catatonia, which involves fever, autonomic instability, and organ stress on top of the usual motor symptoms, carried a mortality rate exceeding 75% before modern treatments existed. That figure has dropped to around 10% in recent reports, though untreated malignant catatonia still kills roughly half of those affected.
Treatment Response Rates
The good news is that catatonia responds well to treatment when it’s actually recognized. Benzodiazepines are the standard first-line approach, and roughly 86% of patients become free of catatonia after a benzodiazepine protocol in studies of medically caused cases. This high response rate is one of the reasons underdiagnosis is so frustrating to specialists in the field: catatonia is both common and treatable, yet most cases never receive the right intervention.
For patients who don’t respond to benzodiazepines, electroconvulsive therapy has the strongest evidence for resolving symptoms, particularly in malignant catatonia where the stakes are highest. The combination of a clear diagnostic framework, effective first-line treatment, and high response rates makes catatonia one of the more actionable diagnoses in psychiatry, if clinicians think to look for it.